Caricamento...
Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera
The first commercially approved human gene therapy in the Western world is Glybera (alipogene tiparvovec), which is an adenoassociated viral vector encoding the lipoprotein lipase gene. Glybera was recommended for marketing authorization by the European Medicines Agency in 2012. The European Medicin...
Salvato in:
| Pubblicato in: | Mol Ther Methods Clin Dev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4449026/ https://ncbi.nlm.nih.gov/pubmed/26052534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2014.66 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|